Anteris Reports 2025 Financial Results and Provides Corporate Update
Globe Newswire (Thu, 26-Feb 6:00 PM ET)
Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays
Globe Newswire (Mon, 23-Feb 6:30 AM ET)
Medtronic’s $90 Million Investment Propels Anteris’ TAVR Ambitions—What’s Next for the DurAVR Valve?
Market Chameleon (Fri, 23-Jan 3:31 AM ET)
Globe Newswire (Thu, 22-Jan 4:02 PM ET)
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
Globe Newswire (Thu, 22-Jan 4:01 PM ET)
Market Chameleon (Wed, 21-Jan 2:06 AM ET)
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
Globe Newswire (Tue, 20-Jan 10:53 PM ET)
Globe Newswire (Tue, 20-Jan 4:01 PM ET)
Market Chameleon (Tue, 28-Oct 3:46 AM ET)
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Anteris Technologies Glb trades on the NASDAQ stock market under the symbol AVR.
As of April 2, 2026, AVR stock price climbed to $5.37 with 283,013 million shares trading.
AVR has a beta of 1.95, meaning it tends to be more sensitive to market movements. AVR has a correlation of 0.10 to the broad based SPY ETF.
AVR has a market cap of $520.08 million. This is considered a Small Cap stock.
Last quarter Anteris Technologies Glb reported $310,000 in Revenue and -$.75 earnings per share. This beat revenue expectation by $2,500 and missed earnings estimates by -$.19.
The top ETF exchange traded funds that AVR belongs to (by Net Assets): IWM, VXF, IWO, VTWO, IWC.
AVR has outperformed the market in the last year with a return of +57.9%, while the SPY ETF gained +17.9%. In the last 3 month period, AVR beat the market returning +7.6%, while SPY returned -3.8%. However, in the most recent 2 weeks AVR has underperformed the stock market by returning -8.8%, while SPY returned -0.9%.
AVR support price is $5.10 and resistance is $5.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVR shares will trade within this expected range on the day.